What Happens After a Clinical Trial Ends?

Most information about clinical trials focuses on getting started: finding a study, screening, and giving consent. But many participants are just as curious about the end. *Will I find out what I received? Can I keep taking the treatment if it worked? When will the results come out?*

Here is what typically happens after a clinical trial ends, and the questions to ask so you know what to expect.

The final study visit

Most studies end with a final visit, sometimes called an "end of study" or "closeout" visit. It often looks similar to your earlier visits and may include:

• A physical exam and vital signs
• Blood or urine tests
• Questions about how you feel and any side effects
• Returning study devices, diaries, or unused medication
• A review of what happens next

If you received a study medication, the team may also explain whether you need to stop it gradually and what to do if symptoms return.

Follow-up after the last visit

Your participation may not end on the day of the final visit. Depending on the study, you might be asked to:

• Attend safety follow-up visits weeks or months later, to check for delayed side effects.
• Answer follow-up phone calls or surveys about your health.
• Allow long-term follow-up through medical records.

Some types of treatment require much longer follow-up. For example, the FDA recommends that participants in certain gene therapy studies be followed for many years — up to 15 years for some products — because effects may appear long after treatment.

Your consent form should explain any follow-up requirements. If it does not, ask the team how long your involvement will last.

Can I keep receiving the treatment?

This is often the most important question for participants who felt the study treatment helped them. The honest answer: it depends, and it is not guaranteed.

Possible paths include:

• Open-label extension studies. Some trials offer a follow-on study in which participants, sometimes including those who received placebo, can receive the study treatment. These are separate studies with their own consent forms and eligibility rules.
• Expanded access (sometimes called "compassionate use"). In some cases, people with serious conditions may be able to get an investigational product outside a clinical trial through an FDA expanded access pathway. This requires the sponsor's agreement and involves your doctor.
• Waiting for approval. If the treatment is eventually approved, your doctor may be able to prescribe it. Approval can take years, and not every treatment that is studied gets approved.
• Returning to standard care. Often, participants go back to the treatment they were on before, or to whatever their doctor recommends.

If continued access matters to you, ask before you enroll — not after the study ends — whether the study has an extension or a plan for post-trial access.

Will I find out which group I was in?

In blinded studies, neither you nor the study team may know whether you received the active treatment or a placebo. Whether and when you find out depends on the study.

Many studies reveal group assignments only after the entire study is complete and the data have been locked and analyzed. That can be months or even years after your last visit. Some studies do not routinely share individual assignments at all. Ask the team what their policy is and how they will contact you.

When will the results be available?

Clinical trials can take a long time to analyze, especially if many sites are involved. Once the study is complete:

• ClinicalTrials.gov: For many trials of drugs and devices regulated by the FDA, U.S. law requires the sponsor to post summary results on ClinicalTrials.gov, generally within one year of the study's primary completion date. You can look up your study by its NCT number to check.
• Scientific publications: Results may be published in a medical journal, though publication timelines vary and not every study is published.
• Plain-language summaries: Some sponsors send participants a lay summary written in everyday language. In the European Union, sponsors are required to provide these for many trials. Others do so voluntarily.

Keep in mind that the results describe what happened across all participants. They usually will not tell you how the treatment affected you personally.

Will I get my own test results?

Studies collect a lot of information — blood tests, scans, measurements — but they do not always share individual results with participants. Some results are only meaningful when combined with everyone else's, and some tests done in research labs are not validated for medical decisions.

That said, many studies will tell you about results that matter for your health, such as an abnormal lab value found during screening. Ask:

• Will I receive copies of my test results?
• Will you share any findings that are important for my health?
• Can you send a summary to my regular doctor?

Returning to your regular care

Make the transition back to your usual care as smooth as possible:

• Ask the study team for a summary of your participation, including any relevant test results and side effects.
• Share this information with your regular doctor.
• Ask whether there are any symptoms to watch for after stopping the study treatment.
• Keep the study team's contact information in case questions come up later.
• Update your doctor about any medications you started or stopped during the study.

Compensation at the end of a study

If your study offered payment, ask when the final payment will be made and whether follow-up visits or calls are also compensated. Payment timelines vary, so it helps to confirm the schedule in writing. And remember that in the U.S., study compensation is generally taxable income.

Can I join another study?

Usually yes, but there may be a waiting period, especially if you received an investigational medication. This helps make sure the previous treatment has cleared your body before you start something new. Be honest with any new study team about your recent participation.

Questions to ask before your last visit

1. Are there any follow-up visits, calls, or surveys after the study ends?
2. Do I need to stop the study medication gradually?
3. Is there an extension study or another way to keep receiving the treatment?
4. Will I find out which group I was in? When?
5. How and when will the results be shared?
6. Can you send a summary of my participation to my doctor?
7. When will I receive my final payment, if any?

The bottom line

The end of a clinical trial is a transition, not just a finish line. Knowing what to expect — follow-up, access to treatment, results, and the return to regular care — helps you plan ahead and get the most from your participation. The best time to ask these questions is before you enroll, but it is never too late to ask your study team.

*This article is for general information only and is not medical advice. Always discuss research participation with a qualified health care professional.*